Publications
361
Citations
17,736
Est. group size
~42
Recurring co-author estimate
Active years
18
Publishing since 2009
Samantha Jaglowski's research focuses on blood cancers such as lymphoma and chronic lymphocytic leukemia (CLL), with particular attention to CAR-T cell therapy (a treatment that reprograms a patient's own immune cells to attack cancer) and stem cell/bone marrow transplantation. Much of the work involves large real-world patient registries (such as CIBMTR) to evaluate how these therapies perform outside of controlled clinical trials, including in older patients and specific disease subtypes. This research is relevant to students interested in clinical/translational oncology, cellular immunotherapy, and outcomes research using large multi-center datasets.
Publication output grew from the late 2010s to a peak around 2019-2021, then has been declining through 2022-2026, with the most recent years showing notably lower counts (though 2025-2026 figures may be incomplete).
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Long-term real-world outcomes of axicabtagene ciloleucel (axi-cel) in relapsed/refractory (R/R) large B-cell lymphoma (LBCL).
Journal of Clinical Oncology · 2026
- Real-world outcomes of lisocabtagene maraleucel (liso-cel) in patients (pt) with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL): First results from CIBMTR.
Journal of Clinical Oncology · 2026
- Outcomes of lisocabtagene maraleucel (liso-cel) in patients (pt) with relapsed or refractory (R/R) mantle cell lymphoma (MCL): First real-world data from the CIBMTR.
Journal of Clinical Oncology · 2026
- Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry
Journal for ImmunoTherapy of Cancer · 2025
- Five-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma
Journal of Clinical Oncology · 2025
- Establishing the Engraft Multi-Center Tri-Use Registry
Transplantation and Cellular Therapy · 2025
- Establishing a Quality Improvement Education Platform in the Engraft Learning Network
Transplantation and Cellular Therapy · 2025
- In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell Therapy
Transplantation and Cellular Therapy · 2024
- Durable Efficacy and Manageable Safety in Patients Age ≥75 Years with Relapsed/Refractory Large B-Cell Lymphoma Treated with Tisagenlecleucel in the Real-World Setting
Transplantation and Cellular Therapy · 2024
- Real-World Tisagenlecleucel Outcomes in Richter-Transformed Chronic Lymphocytic Leukemia: A Center for International Blood & Marrow Transplant Research (CIBMTR) Analysis
Transplantation and Cellular Therapy · 2024
- ABCL-314 Durable Efficacy and Manageable Safety in Patients Aged ≥75 Years With Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL) Treated With Tisagenlecleucel in the Real-World Setting
Clinical Lymphoma Myeloma & Leukemia · 2024
- Durable Efficacy and Manageable Safety in Patients Aged ≥75 Years With Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL) Treated With Tisagenlecleucel in the Real-World Setting
Clinical Lymphoma Myeloma & Leukemia · 2024
- Cell Therapy Informatics: Updates on the Integration of HCT/IEC Functionalities into an Electronic Medical Record System in the US to Promote Efficiency, Patient Safety, Research, and Data Interoperability
Transplantation and Cellular Therapy · 2023
- Improved Overall Survival with Axicabtagene Ciloleucel Vs Standard of Care in Second-Line Large B-Cell Lymphoma Among the Elderly: A Subgroup Analysis of ZUMA-7
Blood · 2023
- Durable Efficacy and Manageable Safety in Patients Age ≥ 75 Years with Relapsed/Refractory Large B-Cell Lymphoma Treated with Tisagenlecleucel in the Real-World Setting
Blood · 2023
- Blood×71
- Transplantation and Cellular Therapy×44
- Biology of Blood and Marrow Transplantation×32
- Journal of Clinical Oncology×21
- Blood Advances×15
- Farrukh T. Awan
Medicine · The Ohio State University
- Adam S. Kittai
Medicine · The Ohio State University
- Seema A. Bhat
Medicine · The Ohio State University
- Jennifer A. Woyach
Medicine · The Ohio State University
- Max Yano
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile